Literature DB >> 1894476

Peripheral color contrast. A new screening test for preglaucomatous visual loss.

T C Yu1, F Falcao-Reis, W Spileers, G B Arden.   

Abstract

A new test of peripheral color contrast is described. A high-definition color monitor driven by a personal computer with a graphics interface card displays an annulus subtending 25 degrees at the eye. The color contrast between the annulus and the background can be varied. Forty-five degrees of the annulus is randomly removed in one of four quadrants. Patients are asked to identify the position of the gap while fixating a central spot. The minimum color contrast between annulus and background at which the identification is possible is between 13-16% for the protan, deuteran, and tritan axis in normal subjects. This threshold value changes little with age, refractive error, or pupillary aperture, and test-retest variability is low. Testing one eye takes only 1-2 min. The test was applied to ocular-hypertensive and glaucomatous patients. All patients with glaucoma had thresholds greater than two standard deviations (SD) above the normal mean. In addition, 97% of glaucoma patients had thresholds greater than four SDs, and 95% had thresholds more than five SDs above the normal mean. Most patients with ocular hypertension and clinical signs indicating a low or medium risk of conversion to glaucoma had thresholds under the upper limit of normal. High-risk patients with ocular hypertension fell into two groups. One approximated to normal; the other had elevated thresholds, which in many cases were more than four SDs above the normal mean. The epidemiologic consequences of this test are discussed.

Entities:  

Mesh:

Year:  1991        PMID: 1894476

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  15 in total

Review 1.  Acquired colour vision defects in glaucoma-their detection and clinical significance.

Authors:  M Pacheco-Cutillas; D F Edgar; A Sahraie
Journal:  Br J Ophthalmol       Date:  1999-12       Impact factor: 4.638

2.  The pattern electroretinogram in glaucoma and ocular hypertension.

Authors:  E O'Donaghue; G B Arden; F O'Sullivan; F Falcão-Reis; B Moriarty; R A Hitchings; W Spilleers; C Hogg; G Weinstein
Journal:  Br J Ophthalmol       Date:  1992-07       Impact factor: 4.638

3.  Ganglion cell loss and age-related visual loss: a cortical pooling analysis.

Authors:  Pauline M Pearson; Laura A Schmidt; Emily Ly-Schroeder; William H Swanson
Journal:  Optom Vis Sci       Date:  2006-07       Impact factor: 1.973

4.  Effect of nimodipine on ocular blood flow and colour contrast sensitivity in patients with normal tension glaucoma.

Authors:  A Luksch; G Rainer; D Koyuncu; P Ehrlich; T Maca; M E Gschwandtner; C Vass; L Schmetterer
Journal:  Br J Ophthalmol       Date:  2005-01       Impact factor: 4.638

5.  [Quality demands on the assessment of colour vision].

Authors:  H Krastel; G Kolling; U Schiefer; M Bach
Journal:  Ophthalmologe       Date:  2009-12       Impact factor: 1.059

6.  Localization of the fourth locus (GLC1E) for adult-onset primary open-angle glaucoma to the 10p15-p14 region.

Authors:  M Sarfarazi; A Child; D Stoilova; G Brice; T Desai; O C Trifan; D Poinoosawmy; R P Crick
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

7.  Mid-peripheral pattern electrical retinal responses in normals, glaucoma suspects, and glaucoma patients.

Authors:  N H Shorstein; W W Dawson; M B Sherwood
Journal:  Br J Ophthalmol       Date:  1999-01       Impact factor: 4.638

8.  Video color perimetry: impairment in glaucoma suspects.

Authors:  N Accornero; M Capozza; A De Feo; S Rinalduzzi; M De Marinis; J Pecori-Giraldi; A Mollicone; V Volante
Journal:  Doc Ophthalmol       Date:  2001-09       Impact factor: 2.379

9.  Colour vision testing as an aid to diagnosis and management of age related maculopathy.

Authors:  G B Arden; J E Wolf
Journal:  Br J Ophthalmol       Date:  2004-09       Impact factor: 4.638

10.  Colour contrast sensitivity in patients with soft drusen, an early stage of ARM.

Authors:  C Frennesson; U L Nilsson; S E Nilsson
Journal:  Doc Ophthalmol       Date:  1995       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.